Journal of Dermatological Science
Volume 59, Issue 2 , Pages 107-114 , August 2010

Perturbation of lamellar granule secretion by sodium caprate implicates epidermal tight junctions in lamellar granule function

  • Shohei Kuroda

      Affiliations

    • Pola Chemical Industries, Inc., 560 Kashio-cho, Totsuka-ku, Yokohama 244-0812, Japan
  • ,
  • Masumi Kurasawa

      Affiliations

    • Pola Chemical Industries, Inc., 560 Kashio-cho, Totsuka-ku, Yokohama 244-0812, Japan
  • ,
  • Koji Mizukoshi

      Affiliations

    • Pola Chemical Industries, Inc., 560 Kashio-cho, Totsuka-ku, Yokohama 244-0812, Japan
  • ,
  • Tetsuo Maeda

      Affiliations

    • Pola Chemical Industries, Inc., 560 Kashio-cho, Totsuka-ku, Yokohama 244-0812, Japan
  • ,
  • Takuya Yamamoto

      Affiliations

    • Pola Chemical Industries, Inc., 560 Kashio-cho, Totsuka-ku, Yokohama 244-0812, Japan
  • ,
  • Ai Oba

      Affiliations

    • Pola Chemical Industries, Inc., 560 Kashio-cho, Totsuka-ku, Yokohama 244-0812, Japan
  • ,
  • Mari Kishibe

      Affiliations

    • Department of Dermatology, Asahikawa Medical College, 2-1-1-1 Midorigaoka Higashi, Asahikawa 078-8510, Japan
  • ,
  • Akemi Ishida-Yamamoto

      Affiliations

    • Department of Dermatology, Asahikawa Medical College, 2-1-1-1 Midorigaoka Higashi, Asahikawa 078-8510, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 166 68 2523; fax: +81 166 68 2529.

Received 13 November 2009 ,Revised 5 June 2010 ,Accepted 9 June 2010.

References 

  1. Elias PM, Cullander C, Mauro T, Rassner U, Komuves L, Brown BE, et al. The secretory granular cell: the outermost granular cell as a specialized secretory cell. J Investig Dermatol Symp Proc. 1998;3:87–100
  2. Madison KC, Sando GN, Howard EJ, True CA, Gilbert D, Swartzendruber DC, et al. Lamellar granule biogenesis: a role for ceramide glucosyltransferase, lysosomal enzyme transport, and the Golgi. J Investig Dermatol Symp Proc. 1998;3:80–86
  3. Ishida-Yamamoto A, Simon M, Kishibe M, Miyauchi Y, Takahashi H, Yoshida S, et al. Epidermal lamellar granules transport different cargoes as distinct aggregates. J Invest Dermatol. 2004;122:1137–1144
  4. Elias PM, Choi EH. Interactions among stratum corneum defensive functions. Exp Dermatol. 2005;14:719–726
  5. Hayward AF. Membrane-coating granules. Int Rev Cytol. 1979;59:97–127
  6. Odland GF, Holbrook K. The lamellar granules of epidermis. Curr Probl Dermatol. 1981;9:29–49
  7. Milner ME, O’Guin WM, Holbrook KA, Dale BA. Abnormal lamellar granules in harlequin ichthyosis. J Invest Dermatol. 1992;99:824–829
  8. Akiyama M, Shimizu H. An update on molecular aspects of the non-syndromic ichthyosis. Exp Dermatol. 2008;17:373–382
  9. Lefevre C, Audebert S, Jobard F, Bouadjar B, Lakhdar H, Boughdene-Stambouli O, et al. Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2. Hum Mol Genet. 2003;12:2369–2378
  10. Tartaglia-Polcini A, Bonnart C, Micheloni A, Cianfarani F, Andre A, Zambruno G, et al. SPINK5, the defective gene in Netherton syndrome, encodes multiple LEKTI isoforms derived from alternative pre-mRNA processing. J Invest Dermatol. 2006;126:315–324
  11. Hansson L, Backman A, Ny A, Edlund M, Ekholm E, Ekstrand HB, et al. Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J Invest Dermatol. 2002;118:444–449
  12. Egberts F, Heinrich F, Jensen JM, Winoto-Morbach S, Pfeiffer S, Wickel M, et al. Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiation. J Cell Sci. 2004;117:2295–2307
  13. Rassner U, Feingold KR, Crumrine DA, Elias PM. Coordinate assembly of lipids and enzyme proteins into epidermal lamellar bodies. Tissue Cell. 1999;31:489–498
  14. Ishida-Yamamoto A, Deraison C, Bonnart C, Bitoun E, Robinson R, O’Brien TJ, et al. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum. J Invest Dermatol. 2005;124:360–366
  15. Sprecher E, Ishida-Yamamoto A, Mizrahi-Koren M, Rapaport D, Goldsher D, Indelman M, et al. A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma. Am J Hum Genet. 2005;77:242–251
  16. Yamamoto T, Kurasawa M, Hattori T, Maeda T, Nakano H, Sasaki H. Relationship between expression of tight junction-related molecules and perturbed epidermal barrier function in UVB-irradiated hairless mice. Arch Dermatol Res. 2008;300:61–68
  17. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol. 2002;156:1099–1111
  18. Hadj-Rabia S, Baala L, Vabres P, Hamel-Teillac D, Jacquemin E, Fabre M, et al. Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease. Gastroenterology. 2004;127:1386–1390
  19. Kurasawa M, Kuroda S, Kida N, Murata M, Oba A, Yamamoto T, et al. Regulation of tight junction permeability by sodium caprate in human keratinocytes and reconstructed epidermis. Biochem Biophys Res Commun. 2009;381:171–175
  20. Yamamoto T, Saeki Y, Kurasawa M, Kuroda S, Arase S, Sasaki H. Effect of RNA interference of tight junction-related molecules on intercellular barrier function in cultured human keratinocytes. Arch Dermatol Res. 2008;300:517–524
  21. Fartasch M, Ponec M. Improved barrier structure formation in air-exposed human keratinocyte culture systems. J Invest Dermatol. 1994;102:366–374
  22. Madison KC, Howard EJ. Ceramides are transported through the Golgi apparatus in human keratinocytes in vitro. J Invest Dermatol. 1996;106:1030–1035
  23. Marks DL, Singh RD, Choudhury A, Wheatley CL, Pagano RE. Use of fluorescent sphingolipid analogs to study lipid transport along the endocytic pathway. Methods. 2005;36:186–195
  24. Pagano RE, Chen CS. Use of BODIPY-labeled sphingolipids to study membrane traffic along the endocytic pathway. Ann N Y Acad Sci. 1998;845:152–160
  25. Pagano RE, Martin OC, Kang HC, Haugland RP. A novel fluorescent ceramide analogue for studying membrane traffic in animal cells: accumulation at the Golgi apparatus results in altered spectral properties of the sphingolipid precursor. J Cell Biol. 1991;13:1267–1279
  26. Chen CS, Bach G, Pagano RE. Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc Natl Acad Sci USA. 1998;95:6373–6378
  27. Bitoun E, Micheloni A, Lamant L, Bonnart C, Tartaglia-Polcini A, Cobbold C, et al. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. Hum Mol Genet. 2003;12:2417–2430
  28. Raghunath M, Tontsidou L, Oji V, Aufenvenne K, Schürmeyer-Horst F, Jayakumar A, et al. SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases. J Invest Dermatol. 2004;123:474–483
  29. Ishida-Yamamoto A, Mizukoshi K. Electron microscopic and immunoelectron microscopic examinations of the skin. J Med Technol. 2006;50:893–896
  30. Salama NN, Eddington ND, Fasano A. Tight junction modulation and its relationship to drug delivery. Adv Drug Deliv Rev. 2006;58:15–28
  31. Jayakumar A, Kang Y, Henderson Y, Mitsudo K, Liu X, Briggs K, et al. Consequences of C-terminal domains and N-terminal signal peptide deletions on LEKTI secretion, stability, and subcellular distribution. Arch Biochem Biophys. 2005;435:89–102
  32. Deraison C, Bonnart C, Lopez F, Besson C, Robinson R, Jayakumar A, et al. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol Biol Cell. 2007;18:3607–3619
  33. Matoltsy AG, Parakkal PF. Membrane-coating granules of keratinizing epithelia. J Cell Biol. 1994;24:297–307
  34. Merril AH. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem. 2002;277:25843–25846
  35. Van Meer G, Lisman Q. Sphingolipid transport: rafts and translocators. J Biol Chem. 2002;277:25855–25858
  36. Watanabe R, Wu K, Paul P, Marks DL, Kobayashi T, Pittelkow MR, et al. Up-regulation of glycosylceramide synthase expression and activity during human keratinocyte differentiation. J Biol Chem. 1998;273:9651–9655
  37. Balda MS, Whitney JA, Flores C, González S, Cereijido M, Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol. 1996;134(4):1031–1049
  38. Hernandez S, Chavez Munguia B, Gonzalez-Mariscal L. ZO-2 silencing in epithelial cells perturbs the gate and fence function of tight junctions and leads to an atypical monolayer architecture. Exp Cell Res. 2007;313(8):1533–1547
  39. Umeda K, Ikenouchi J, Katahira-Tayama S, Furuse K, Sasaki H, Nakayama M, et al. ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell. 2006;126:741–754
  40. Yu W, Fang X, Ewald A, Wong K, Hunt CA, Werb Z, et al. Formation of cysts by alveolar type II cells in three-dimensional culture reveals a novel mechanism for epithelial morphogenesis. Mol Biol Cell. 2007;18:1693–1700
  41. Guo Y, Martinez-Williams C, Yellowley CE, Donahue HJ, Rannels DE. Connexin expression by alveolar epithelial cells is regulated by extracellular matrix. Am J Physiol Lung Cell Mol Physiol. 2001;280:L191–202
  42. Roelandt T, Giddelo C, Heughebaert C, Denecker G, Hupe M, Crumrine D, et al. The “Caveolae Brake hypothesis” and the epidermal barrier. J Invest Dermatol. 2009;129:927–936
  43. Hayashi M, Tomita M. Mechanistic analysis for drug permeation through intestinal membrane. Drug Metab Pharmacokinet. 2007;22:67–77

PII: S0923-1811(10)00193-3

doi: 10.1016/j.jdermsci.2010.06.001

Journal of Dermatological Science
Volume 59, Issue 2 , Pages 107-114 , August 2010